Shopping Cart
- Remove All
Your shopping cart is currently empty
Compound PDK0269, as 5-HT3 receptor agonists(3–100 μM, pEC50 5.05±0.06), acutely increased XII (hypoglossal) burst frequency and regularity, and decreased bursts/episode . Phenylbiguanide produced a dose-related (10-500 microM) increase in the release of dopamine (280-2000%). When nomifensine (5 microM) was included in the Ringer solution, the effect of Compound PDK0269 on the release of dopamine was ameliorated or inhibited.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 200 mg | $29 | In Stock |
| Description | Compound PDK0269, as 5-HT3 receptor agonists(3–100 μM, pEC50 5.05±0.06), acutely increased XII (hypoglossal) burst frequency and regularity, and decreased bursts/episode . Phenylbiguanide produced a dose-related (10-500 microM) increase in the release of dopamine (280-2000%). When nomifensine (5 microM) was included in the Ringer solution, the effect of Compound PDK0269 on the release of dopamine was ameliorated or inhibited. |
| Targets&IC50 | 5-HT3 receptor:3 μM (EC50) |
| Synonyms | Phenylbiguanide hydrochloride |
| Molecular Weight | 213.67 |
| Formula | C8H12ClN5 |
| Cas No. | 55-57-2 |
| Smiles | Cl.NC(N)=NC(=N)NC1=CC=CC=C1 |
| Relative Density. | 1.33g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.